Bioactive Scaffold for Tendon Regeneration via ECM Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue-engineered tendon products face challenges such as limited supply, antigenicity, poor mechanical compatibility, and inefficient tendon regeneration due to partial loss of bioactive factors during processing, making them unsuitable for broad clinical application.
Innovation Solution
A bioactive scaffold is prepared by decellularizing tendon tissue and adding extracellular matrix materials, including growth factors like TGF-β1, IGF-1, and VEGF, to enhance tendon regeneration, with a method involving freezing, thawing, nuclease treatment, and ECM modification to create a scaffold with improved mechanical properties and bioactivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If decellularized tendon slices are used as scaffolds, then antigenicity is reduced, but bioactive factors are partially lost
Solution Approach 1:
The invention extracts and isolates specific bioactive factors (TGF-β1, IGF-1, VEGF) from the decellularized tendon scaffold, separating them from the bulk material. This allows the scaffold to maintain its low antigenicity while the extracted factors are concentrated and applied to enhance tendon regeneration, thus resolving the contradiction between reducing antigenicity and preserving bioactive factors.
Solution Approach 2:
The decellularized tendon scaffold serves multiple functions: it provides a structural framework with low antigenicity, while simultaneously serving as a source for extracting concentrated bioactive factors. The scaffold thus performs both structural support and biological activation functions, resolving the contradiction between antigen reduction and bioactive factor preservation.
2Ease of manufacture
If traditional tissue-engineered tendon products are used, then production is established, but they face limited supply and high cost
Solution Approach 1:
Instead of using rare human tendon tissues or limited allogenic grafts, the invention creates artificial copies using abundant decellularized animal tendon tissues as templates. These engineered scaffolds replicate the functional properties of natural tendon tissue but can be produced in large quantities from readily available animal sources, thus resolving the contradiction between established production methods and limited supply efficiency.
3Shape
If artificial materials are used for tendon repair, then mechanical properties can be controlled, but they show poor mechanical compatibility and mismatched degradation rates
Solution Approach 1:
The invention changes the fundamental parameter of scaffold material composition from synthetic polymers to naturally-derived decellularized tendon extracellular matrix. This natural origin ensures that the mechanical properties and degradation rate naturally match those of native tendon tissue, resolving the contradiction between controllable mechanical properties and mechanical compatibility by using biologically-derived materials whose properties inherently align with the target tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioactive scaffold effectively induces tendon regeneration with enhanced mechanical compatibility and bioactivity, facilitating cell adhesion and proliferation, and is suitable for large-scale production and clinical application.
Implementation Method 1
freezing, thawing, nuclease treatment
Implementation Method 2
nuclease treatment comprises placing the tendon sheet in a solution having DNase at a concentration of 120 to 180 IU/ml and RNase at a concentration of 80 to 120 μg/ml
Data Source
AI summary
Provided is a method of preparing a bioactive scaffold for inducing tendon regeneration, the method includes decellularizing a fresh tendon tissue and to obtain a decellularized tendon sheet scaffold or slice scaffold, and adding ECM materials to the decellularized tendon sheet scaffold or slice scaffold.